e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Airway diseases: from invasive to noninvasive biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Short-term and long-term reproducibility of non-invasive clinical and inflammatory parameters in asthma
M. Jung, S. Korn, M. Hübner, C. Taube, R. Buhl (Mainz, Germany; Leiden, Netherlands)
Source:
Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Session:
Airway diseases: from invasive to noninvasive biomarkers
Session type:
Poster Discussion
Number:
304
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Jung, S. Korn, M. Hübner, C. Taube, R. Buhl (Mainz, Germany; Leiden, Netherlands). Short-term and long-term reproducibility of non-invasive clinical and inflammatory parameters in asthma. Eur Respir J 2012; 40: Suppl. 56, 304
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Variability and lack of predictive ability of asthma end-points in clinical trials
Source: Eur Respir J 2002; 20: 1102-1109
Year: 2002
Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006
Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice
Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019
Year: 2020
Comparable efficacy of calcilytic and corticosteroid in short-term and long-term allergic asthma models in vivo
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Inflammatory biomarkers in the evaluation of two-year outcomes of omalizumab treatment in severe allergic asthma.
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
The usefulness of the impulse oscillometry for predicting the treatment outcomes of bronchial thermoplasty in patients with severe asthma.
Source: International Congress 2018 – Asthma analysis
Year: 2018
Clustering of adherence variability metrics and clinical outcomes in asthma
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy?
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006
Accuracy in assessment of acute asthma needs improved to avoid potential adverse outcomes
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012
Follow-up of patients with severe asthma by noninvasive parameters of airway inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 52s
Year: 2001
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Relationship between omalizumab efficacy and baseline allergen profile impacts patient-reported outcomes in allergic asthma
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018
Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD?
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies?
Source: Eur Respir J 2006; 27: 248-249
Year: 2006
Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD
Source: Eur Respir J 2013; 42: 891-892
Year: 2013
Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
Cardiac biomarkers and long-term outcomes of exacerbations of COPD: a long-term follow-up of two cohorts
Source: ERJ Open Res, 7 (1) 00531-2020; 10.1183/23120541.00531-2020
Year: 2021
Long-term efficacy of QMF149 in persistent asthma
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012
The usefulness of the simultaneous measurement of IOS and FeNO in the management of asthma
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept